Bonesupport Holding AB (publ) (BOEUF)
- Previous Close
22.89 - Open
22.50 - Bid --
- Ask --
- Day's Range
22.41 - 22.50 - 52 Week Range
5.88 - 22.89 - Volume
23,015 - Avg. Volume
47 - Market Cap (intraday)
1.506B - Beta (5Y Monthly) --
- PE Ratio (TTM)
58.98 - EPS (TTM)
0.38 - Earnings Date Jul 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management. In addition, the company develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, and foot and ankle surgery. The company was founded in 1999 and is headquartered in Lund, Sweden.
www.bonesupport.comRecent News: BOEUF
Performance Overview: BOEUF
Trailing total returns as of 5/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BOEUF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BOEUF
Valuation Measures
Market Cap
1.49B
Enterprise Value
1.47B
Trailing P/E
58.73
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
24.04
Price/Book (mrq)
27.32
Enterprise Value/Revenue
24.05
Enterprise Value/EBITDA
258.89
Financial Highlights
Profitability and Income Statement
Profit Margin
40.65%
Return on Assets (ttm)
6.12%
Return on Equity (ttm)
62.97%
Revenue (ttm)
655.75M
Net Income Avi to Common (ttm)
266.56M
Diluted EPS (ttm)
0.38
Balance Sheet and Cash Flow
Total Cash (mrq)
187.21M
Total Debt/Equity (mrq)
2.90%
Levered Free Cash Flow (ttm)
13.56M
Research Analysis: BOEUF
Company Insights: BOEUF
BOEUF does not have Company Insights